PAHC NASDAQ
Phibro Animal Health Corporation
1W: -1.1%
1M: +7.5%
3M: +3.9%
YTD: +3.1%
1Y: -9.1%
3Y: +244.8%
5Y: +99.8%
$38.38
-0.65 (-1.67%)
Weekly Expected Move ±4.4%
$35
$37
$39
$41
$42
Credit Risk of going bust: higher than 69% of companies Debt: 33.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.82 (down 95%), Phibro Animal Health Corporation would be worth roughly what it owes.
Total debt $788.8M against a stock market value of $1.56B.
Distance to default 3.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $378.9M (short-term plus half of long-term), stock volatility 55.2%; Altman Z 3.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $1.82 (down 95%), Phibro Animal Health Corporation would be worth roughly what it owes.
Total debt $788.8M against a stock market value of $1.56B.
Distance to default 3.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $378.9M (short-term plus half of long-term), stock volatility 55.2%; Altman Z 3.08. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.30
Neutral
2 bullish
0 neutral
1 bearish
Articles (24h)
3
Hourly Sentiment (24h)
0.35
Bullish
10 bullish
5 neutral
3 bearish
Articles (7d)
18
Daily Sentiment (7 Days)
Articles (100)
ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Centene Q3 Earnings Beat Estimates on Medicare Strength
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
DexCom Gears Up to Report Q3 Results: How to Play the Stock?
Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures?
Zacks Research Issues Positive Forecast for PAHC Earnings
Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Is This the Right Time to Hold EW Stock in Your Portfolio?
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?
PAHC or SYK: Which Is the Better Value Stock Right Now?
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?
Ecolab Gears Up to Report Q3 Results: How to Play the Stock?
Reasons to Add STE Stock to Your Portfolio Right Now
Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital
UNH Tops Q3 Earnings on Lower Medical Costs, Raises '26 Outlook
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
Is it the Right Time to Add Phibro Stock to Your Portfolio?
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools
Encompass Health Expands Rehab Footprint With New Maine Hospital
Is This the Right Time to Add TMO Stock to Your Portfolio?
PAHC vs. HAE: Which Stock Is the Better Value Option?
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
Should You Continue to Hold IART Stock in Your Portfolio?
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
Best Momentum Stocks to Buy for September 21st
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Should Value Investors Buy Envista (NVST) Stock?
Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?
Phibro Animal Health Corporation $PAHC Shares Acquired by Engineers Gate Manager LP
Zacks.com featured highlights DiamondRock, Vertiv, Mueller Water Products and Phibro
4 Stocks With Strong Interest Coverage to Buy as Yields Rise
Chewy Leverages AI for Productivity Gains and Margin Expansion
Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
PAHC or LMAT: Which Is the Better Value Stock Right Now?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Understanding Phibro (PAHC) Reliance on International Revenue
Phibro (PAHC) Q4 2026 Earnings Call Transcript
At a glance: stocks gapping up premarket
Phibro (PAHC) Reports Q4 Earnings: What Key Metrics Have to Say
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Here are the major earnings after the close Wednesday
Phibro (PAHC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Should You Continue to Retain PAHC Stock in Your Portfolio?
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
SOLV Plans Health Information Systems Business Spinoff to Drive Growth
Phibro Animal Health (NASDAQ:PAHC) Shares Cross Below 200 Day Moving Average – Here’s What Happened
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up
Rigetti Q2 Earnings Miss Estimates on Higher Costs, Revenue Beat
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates
Haemonetics (HAE) Tops Q1 Earnings and Revenue Estimates
TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract
BrightSpring Q2 Earnings Beat on Specialty Growth, '26 View Raised
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
TEM Q2 Loss Narrower Than Expected, Revenues Beat, Stock Up
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
Phibro Animal declares $0.12 dividend
Tilray Brands, Inc. (TLRY) Reports Q4 Loss, Beats Revenue Estimates
Ecolab Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates
Central Garden Expands Europe Pet Business With TRIXIE Acquisition
PAHC vs. SYK: Which Stock Is the Better Value Option?
WST Stock Jumps on Q2 Earnings & Sales Beat, EPS View Up on HVP Growth
Reasons to Retain Align Technology Stock in Your Portfolio for Now
DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Reasons to Retain Globus Medical Stock in Your Portfolio for Now
GMED Stock Surges 43.6% in a Year: What's Driving the Rally?
Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Reasons to Retain Abbott Stock in Your Portfolio for Now
IART Stock Surges 52.1% in a Year: What's Driving the Rally?
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
How Pet Healthcare Could Shape Chewy's Future Growth & Profitability?
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Can Cost & Simplicity Program Keep Expanding Central Garden's Margins?
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?